Iovance Biotherapeutics (IOVA) News Today
IOVA fell 1.29% in the 10 minutes after this headline crossed at 10:15:00 ET on Friday, Oct 23:
Iovance presents ESMO 2026 data showing deep, durable responses to lifileucel TIL cell therapy plus pembrolizumab in frontline advanced melanoma
Price 13.96 two minutes before the headline, 13.78 10 minutes after it.
Latest headline on this page:
1 headline on Iovance Biotherapeutics appeared in our news feed in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was -1.29% over 10 minutes on IOVA, after the headline at Oct 23, 10:15:00 ET.
Price action when the news broke
10:15:00 ET
What moved IOVA — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Oct 23, 10:15:00 ET | Iovance presents ESMO 2026 data showing deep, durable responses to lifileucel TIL cell therapy plus pembrolizumab in frontline advanced melanomaVolume 676.9K shares in 10 min · 2.5× normal | -0.50% | -1.29% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.